Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients - Estimabl
This is a multicentric, randomized, controlled, open-label phase III clinical trial
involving 26 French centers. It aims at comparing four strategies of management of
postoperative radioiodine ablation, each strategy combining a method of TSH stimulation
(thyroid hormone withdrawal or rhTSH (Thyrogen®, Genzyme)) and an activity of 131I (low-dose
(1GBq, 30 mCi) or high-dose (3,7GBq, 100 mCi)).
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
the rate of successful postoperative thyroid ablation
Martin SCHLUMBERGER, PhD
Principal Investigator
Gustave Roussy, Cancer Campus, Grand Paris
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Estimabl
NCT00435851
February 2007
Name | Location |
---|